Industry News (Patents and Technology)

Antigen-Specific T-Cell Expansion Broad Patent Issuance Announced

Published in Cancer Weekly, November 9th, 1998

Fred Hutchinson Cancer Research Center, Seattle, Washington, and Targeted Genetics Corp. announced that they have received notification from the U.S. Patent and Trademark Office regarding the issuance of a patent entitled, "Rapid Expansion Method ("REM") for in vitro Propagation of T Lymphocytes."

The patent covers technology to expand antigen-specific T cells for use in adoptive immunotherapy, which has the potential to treat diseases such as cancer and viral infections.

The process covered by the patent enables large numbers of antigen-specific T cells (CD4+ or CD8+ T lymphocytes) to be produced from an initially very small number of such cells. ...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1998-11-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry